Regulation of brain-derived neurotrophic factor (BDNF) and cerebral dopamine neurotrophic factor (CDNF) by anti-parkinsonian drug therapy in vivo

Cellular and Molecular Neurobiology

Volumn 30, Issue 3, 2010, Pages 361-368

  Gyárfás, Tobias ^a,b   Knuuttila, Juha ^a   Lindholm, Päivi ^c   Rantamäki, Tomi ^a   Castrén, Eero ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Adenosine antagonist; BDNF; CDNF; MAO inhibitor; Neuroprotection; Parkinson's disease; SCH 58261; Selegiline; Striatum; Substantia nigra

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CEREBRAL DOPAMINE NEUROTROPHIC FACTOR; NEUROTROPHIC FACTOR; PLACEBO; SELEGILINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CINGULATE GYRUS; CONTROLLED STUDY; CORPUS STRIATUM; HIPPOCAMPUS; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; NUCLEUS ACCUMBENS; PARIETAL LOBE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIPARKINSON AGENTS; BLOTTING, WESTERN; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CORPUS STRIATUM; CYTOPROTECTION; GYRUS CINGULI; MALE; MICE; MICE, INBRED C57BL; MONOAMINE OXIDASE INHIBITORS; NERVE GROWTH FACTORS; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE; PYRIMIDINES; RECEPTOR, ADENOSINE A2A; SELEGILINE; TRIAZOLES; UP-REGULATION;

ANIMALIA; PARKINSONIA;

EID: 77952097251     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-009-9458-3     Document Type: Article

References (53)

1. MS Airaksinen M Saarma 2002 The GDNF family: signalling, biological functions and therapeutic value Nat Rev Neurosci 3 383 394 10.1038/nrn812 1:CAS:528:DC%2BD38XjsFynu74%3D 11988777 (Pubitemid 135706635)
2. MS Airaksinen A Titievsky M Saarma 1999 GDNF family neurotrophic factor signaling: four masters, one servant? Mol Cell Neurosci 13 313 325 10.1006/mcne.1999.0754 1:CAS:528:DyaK1MXjsVGjsb4%3D 10356294 (Pubitemid 29256872)
3. CA Altar N Cai T Bliven M Juhasz JM Conner AL Acheson RM Lindsay SJ Wiegand 1997 Anterograde transport of brain-derived neurotrophic factor and its role in the brain Nature 389 856 860 10.1038/39885 1:CAS:528:DyaK2sXmvFSku7c%3D 9349818 (Pubitemid 27462980)
4. F Angelucci L Aloe A Iannitelli SH Gruber AA Mathe 2005 Effect of chronic olanzapine treatment on nerve growth factor and brain-derived neurotrophic factor in the rat brain Eur Neuropsychopharmacol 15 311 317 10.1016/j.euroneuro. 2004.11.005 1:CAS:528:DC%2BD2MXjtlSrtb0%3D 15820421 (Pubitemid 40487735)
5. KS Ansari PH Yu TP Kruck WG Tatton 1993 Rescue of axotomized immature rat-facial motoneurons by R(-)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition J Neurosci 13 4042 4053 1:CAS:528: DyaK2cXmvFemsg%3D%3D 8366359
6. B Chen D Dowlatshahi GM MacQueen JF Wang LT Young 2001 Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication Biol Psychiatry 50 260 265 10.1016/S0006-3223(01)01083-6 1:CAS:528:DC%2BD3MXmtFSru7g%3D 11522260 (Pubitemid 32778442)
7. JF Chen K Xu JP Petzer R Staal YH Xu M Beilstein PK Sonsalla K Castagnoli N Castagnoli Jr MA Schwarzschild 2001 Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease J Neurosci 21 RC143 1:STN:280:DC%2BD3M3pt1aisg%3D%3D 11319241
8. M Ebadi S Sharma S Shavali H El Refaey 2002 Neuroprotective actions of selegiline J Neurosci Res 67 285 289 10.1002/jnr.10148 1:CAS:528: DC%2BD38Xht1Oms78%3D 11813232 (Pubitemid 34137134)
9. M Ebadi H Brown-Borg J Ren S Sharma S Shavali H El ReFaey EC Carlson 2006 Therapeutic efficacy of selegiline in neurodegenerative disorders and neurological diseases Curr Drug Targets 7 1513 1529 1:CAS:528:DC%2BD28XhtFensLrM 17100591
10. A Eslamboli B Georgievska RM Ridley HF Baker N Muzyczka C Burger RJ Mandel L Annett D Kirik 2005 Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease J Neurosci 25 769 777 10.1523/JNEUROSCI.4421-04.2005 1:CAS:528:DC%2BD2MXhtlalsbs%3D 15673656 (Pubitemid 40170991)
11. F Esmaeili T Tiraihi M Movahedin SJ Mowla 2006 Selegiline induces neuronal phenotype and neurotrophins expression in embryonic stem cells Rejuvenation Res 9 475 484 10.1089/rej.2006.9.475 1:CAS:528:DC%2BD28XhtF2ns7jK 17105388 (Pubitemid 46100669)
12. BL Fiebich K Biber K Lieb D van Calker M Berger J Bauer PJ Gebicke-Haerter 1996 Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors Glia 18 152 160 10.1002/(SICI)1098-1136(199610)18: 2<152::AID-GLIA7>3.0.CO;2-2 1:STN:280:DyaK2s%2FntVymsA%3D%3D 8913778 (Pubitemid 27040105)
13. DM Frim TA Uhler WR Galpern MF Beal XO Breakefield O Isacson 1994 Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat Proc Natl Acad Sci USA 91 5104 5108 10.1073/pnas.91.11.5104 1:CAS:528:DyaK2cXktVWqtLk%3D 8197193 (Pubitemid 24177801)
14. T Fukumoto S Morinobu Y Okamoto A Kagaya S Yamawaki 2001 Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain Psychopharmacology 158 1 100 106 10.1007/s002130100871 1:CAS:528:DC%2BD3MXovVCmurY%3D 11685390 (Pubitemid 32938319)
15. DM Gash Z Zhang A Ovadia WA Cass A Yi L Simmerman D Russell D Martin PA Lapchak F Collins BJ Hoffer GA Gerhardt 1996 Functional recovery in parkinsonian monkeys treated with GDNF Nature 380 252 255 10.1038/380252a0 1:CAS:528:DyaK28XhvVahsL8%3D 8637574 (Pubitemid 26090648)
16. SS Gill NK Patel GR Hotton K O'Sullivan R McCarter M Bunnage DJ Brooks CN Svendsen P Heywood 2003 Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease Nat Med 9 589 595 10.1038/nm850 1:CAS:528:DC%2BD3sXjtlamtLw%3D 12669033 (Pubitemid 36597106)
17. CA Gomes SH Vaz JA Ribeiro AM Sebastiao 2006 Glial cell line-derived neurotrophic factor (GDNF) enhances dopamine release from striatal nerve endings in an adenosine A2A receptor-dependent manner Brain Res 1113 129 136 10.1016/j.brainres.2006.07.025 1:CAS:528:DC%2BD28XpvV2kt70%3D 16935271 (Pubitemid 44396946)
18. R Grondin Z Zhang A Yi WA Cass N Maswood AH Andersen DD Elsberry MC Klein GA Gerhardt DM Gash 2002 Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys Brain 125 2191 2201 10.1093/brain/awf234 12244077
19. DY He D Ron 2006 Autoregulation of glial cell line-derived neurotrophic factor expression: implications for the long-lasting actions of the anti-addiction drug, Ibogaine FASEB J 20 2420 2422 10.1096/fj.06-6394fje 1:CAS:528:DC%2BD28XhtF2nurjO 17023388 (Pubitemid 44953846)
20. DW Howells MJ Porritt JY Wong PE Batchelor R Kalnins AJ Hughes GA Donnan 2000 Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra Exp Neurol 166 127 135 10.1006/exnr.2000.7483 1:CAS:528:DC%2BD3cXnt1WjsLk%3D 11031089
21. EJ Huang LF Reichardt 2001 Neurotrophins: roles in neuronal development and function Annu Rev Neurosci 24 677 736 10.1146/annurev.neuro.24.1.677 1:CAS:528:DC%2BD3MXls1ShsL4%3D 11520916 (Pubitemid 32695243)
22. C Hyman M Hofer YA Barde M Juhasz GD Yancopoulos SP Squinto RM Lindsay 1991 BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra Nature 350 230 232 10.1038/350230a0 1:CAS:528:DyaK3MXhslyrtr8%3D 2005978
23. K Ikeda M Kurokawa S Aoyama Y Kuwana 2002 Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease J Neurochem 80 262 270 10.1046/j.0022-3042.2001.00694.x 1:CAS:528:DC%2BD38XptV2jsQ%3D%3D 11902116 (Pubitemid 34809371)
24. R Katoh-Semba R Semba IK Takeuchi K Kato 1998 Age-related changes in levels of brain-derived neurotrophic factor in selected brain regions of rats, normal mice and senescence-accelerated mice: a comparison to those of nerve growth factor and neurotrophin-3 Neurosci Res 31 227 234 10.1016/S0168-0102(98) 00040-6 1:STN:280:DyaK1M%2FisFGnsg%3D%3D 9809668 (Pubitemid 28474939)
25. D Kirik B Georgievska C Rosenblad A Bjorklund 2001 Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease Eur J Neurosci 13 1589 1599 10.1046/j.0953-816x.2001.01534.x 1:STN:280:DC%2BD3MzpsFyitg%3D%3D 11328352 (Pubitemid 32423344)
26. O Kontkanen P Törönen M Lakso G Wong E Castrén 2002 Antipsychotic drug treatment induces differential gene expression in the rat cortex J Neurochem 83 1043 1053 10.1046/j.1471-4159.2002.01213.x 1:CAS:528:DC%2BD38XptlGksb0%3D 12437575 (Pubitemid 35397114)
27. JH Kordower ME Emborg J Bloch SY Ma Y Chu L Leventhal J McBride EY Chen S Palfi BZ Roitberg WD Brown JE Holden R Pyzalski MD Taylor P Carvey Z Ling D Trono P Hantraye N Deglon P Aebischer 2000 Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease Science 290 767 773 10.1126/science.290.5492.767 1:CAS:528:DC%2BD3cXns1akur4%3D 11052933
28. JH Kordower CD Herzog B Dass RA Bakay J Stansell 3rd M Gasmi RT Bartus 2006 Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys Ann Neurol 60 706 715 10.1002/ana.21032 1:CAS:528:DC%2BD2sXhsFeqtLY%3D 17192932 (Pubitemid 46048488)
29. AE Lang S Gill NK Patel A Lozano JG Nutt R Penn DJ Brooks G Hotton E Moro P Heywood MA Brodsky K Burchiel P Kelly A Dalvi B Scott M Stacy D Turner VG Wooten WJ Elias ER Laws V Dhawan AJ Stoessl J Matcham RJ Coffey M Traub 2006 Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease Ann Neurol 59 459 466 10.1002/ana.20737 1:CAS:528:DC%2BD28XjtV2lsbY%3D 16429411 (Pubitemid 43358066)
30. B Le Foll J Diaz P Sokoloff 2005 A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning Neuroreport 16 175 178 10.1097/00001756-200502080-00022 1:CAS:528:DC%2BD2MXnt1Shtg%3D%3D 15671872 (Pubitemid 40250395)
31. LF Lin DH Doherty JD Lile S Bektesh F Collins 1993 GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons Science 260 1130 1132 10.1126/science.8493557 1:CAS:528:DyaK2cXks1Gguw%3D%3D 8493557
32. P Lindholm MH Voutilainen J Lauren J Peranen VM Leppanen JO Andressoo M Lindahl S Janhunen N Kalkkinen T Timmusk RK Tuominen M Saarma 2007 Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo Nature 448 73 77 10.1038/nature05957 1:CAS:528:DC%2BD2sXnt1ent7k%3D 17611540 (Pubitemid 47037006)
33. T Matsuya K Takuma K Sato M Asai Y Murakami S Miyoshi A Noda T Nagai H Mizoguchi S Nishimura K Yamada 2007 Synergistic effects of adenosine A2A antagonist and L-DOPA on rotational behaviors in 6-hydroxydopamine-induced hemi-Parkinsonian mouse model J Pharmacol Sci 103 3 329 332 10.1254/jphs. SCZ070058 1:CAS:528:DC%2BD2sXjs1KltLk%3D 17341841 (Pubitemid 46465777)
34. A Melani M Gianfriddo MG Vannucchi S Cipriani PG Baraldi MG Giovannini F Pedata 2006 The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia Brain Res 1073-1074 470 480 10.1016/j.brainres.2005.12.010 16443200
35. L Minghetti A Greco RL Potenza A Pezzola D Blum K Bantubungi P Popoli 2007 Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration J Neuropathol Exp Neurol 66 363 371 10.1097/nen.0b013e3180517477 1:CAS:528: DC%2BD2sXmtVyqsbY%3D 17483693 (Pubitemid 46701318)
36. I Mizuta M Ohta K Ohta M Nishimura E Mizuta K Hayashi S Kuno 2000 Selegiline and desmethylselegiline stimulate NGF, BDNF, and GDNF synthesis in cultured mouse astrocytes Biochem Biophys Res Commun 279 751 755 10.1006/bbrc.2000.4037 1:CAS:528:DC%2BD3MXivValug%3D%3D 11162424 (Pubitemid 32042852)
37. M Mogi A Togari T Kondo Y Mizuno O Komure S Kuno H Ichinose T Nagatsu 1999 Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease Neurosci Lett 270 45 48 10.1016/S0304-3940(99)00463-2 1:CAS:528:DyaK1MXksFait74%3D 10454142 (Pubitemid 29322994)
38. M Nibuya S Morinobu RS Duman 1995 Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments J Neurosci 15 7539 7547 1:CAS:528:DyaK2MXptlOmsLk%3D 7472505
39. K Ohta S Kuno I Mizuta A Fujinami H Matsui M Ohta 2003 Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes Life Sci 73 617 626 10.1016/S0024-3205(03)00321-7 1:CAS:528:DC%2BD3sXktVOru78%3D 12770616 (Pubitemid 36603334)
40. P Petrova A Raibekas J Pevsner N Vigo M Anafi MK Moore AE Peaire V Shridhar DI Smith J Kelly Y Durocher JW Commissiong 2003 MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons J Mol Neurosci 20 173 188 10.1385/JMN:20:2:173 1:CAS:528:DC%2BD3sXkvF2ru7s%3D 12794311 (Pubitemid 36693821)
41. P Popoli C Frank MT Tebano RL Potenza A Pintor MR Domenici V Nazzicone A Pezzola R Reggio 2003 Modulation of glutamate release and excitotoxicity by adenosine A2A receptors Neurology 61 S69 S71 1:CAS:528:DC%2BD3sXptVCltL0%3D 14663014
42. T Rantamäki P Hendolin A Kankaanpää J Mijatovic P Piepponen E Domenici MV Chao PT Männistö E Castrén 2007 Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain Neuropsychopharmacology 32 2152 2162 10.1038/sj.npp.1301345 17314919 (Pubitemid 47417694)
43. N Rebola R Lujan RA Cunha C Mulle 2008 Adenosine A2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses Neuron 57 121 134 10.1016/j.neuron.2007.11.023 1:CAS:528: DC%2BD1cXht1yqs7g%3D 18184569
44. V Ries C Henchcliffe T Kareva M Rzhetskaya R Bland MJ During N Kholodilov RE Burke 2006 Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease Proc Natl Acad Sci USA 103 18757 18762 10.1073/pnas. 0606401103 1:CAS:528:DC%2BD28Xhtlahtb7P 17116866 (Pubitemid 44913483)
45. T Saarelainen P Hendolin G Lucas E Koponen M Sairanen E MacDonald K Agerman A Haapasalo H Nawa R Aloyz P Ernfors E Castrén 2003 Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects J Neurosci 23 349 357 1:CAS:528:DC%2BD3sXktlagug%3D%3D 12514234
46. I Semkova P Wolz M Schilling J Krieglstein 1996 Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage Eur J Pharmacol 315 1 19 30 10.1016/S0014-2999(96)00593-6 1:CAS:528:DyaK28XntFWqu7Y%3D 8960860 (Nov 7) (Pubitemid 26390945)
47. S Sen R Duman G Sanacora 2008 Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications Biol Psychiatry 64 6 527 532 10.1016/j.biopsych.2008.05.005 1:CAS:528: DC%2BD1cXhtVensr%2FM 18571629
48. MT Tebano A Pintor C Frank MR Domenici A Martire R Pepponi RL Potenza R Grieco P Popoli 2004 Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum J Neurosci Res 77 100 107 10.1002/jnr.20138 1:CAS:528:DC%2BD2cXlsFWms7w%3D 15197743 (Pubitemid 38850060)
49. K Tokugawa K Yamamoto M Nishiguchi T Sekine M Sakai T Ueki S Chaki S Okuyama 2003 XIB4035, a novel nonpeptidyl small molecule agonist for GFRalpha-1 Neurochem Int 42 81 86 10.1016/S0197-0186(02)00053-0 1:CAS:528: DC%2BD38XoslCht7s%3D 12441171 (Pubitemid 35346335)
50. A Tomac E Lindqvist LF Lin SO Ogren D Young BJ Hoffer L Olson 1995 Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo Nature 373 335 339 10.1038/373335a0 1:CAS:528:DyaK2MXjtlygtbc%3D 7830766
51. NP Visanji A Orsi TH Johnston PA Howson K Dixon N Callizot JM Brotchie DD Rees 2008 PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease FASEB J 22 2488 2497 10.1096/fj.07-095398 1:CAS:528:DC%2BD1cXotlGntLY%3D 18364399 (Pubitemid 351948666)
52. Q Yan J Elliot WD Snider 1992 Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death Nature 360 753 755 10.1038/360753a0 1:CAS:528:DyaK3sXltlWhtQ%3D%3D 1281520 (Pubitemid 23012274)
53. V Zermeno S Espindola E Mendoza E Hernandez-Echeagaray 2009 Differential expression of neurotrophins in postnatal C57BL/6 mice striatum Int J Biol Sci 5 118 127 1:CAS:528:DC%2BD1MXnsl2rtb8%3D 19173033